Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL - Results From the Phase-II STORM Trial.
Witzens-Harig M, Viardot A, Keller U, Wosniok J, Deuster O, Klemmer J, Geueke AM, Meißner J, Ho AD, Atta J, Marks R, La Rosée P, Buske C, Dreyling MH, Hess G. Witzens-Harig M, et al. Among authors: buske c. Hemasphere. 2021 Sep 23;5(10):e636. doi: 10.1097/HS9.0000000000000636. eCollection 2021 Oct. Hemasphere. 2021. PMID: 34589671 Free PMC article.
[Monoclonal antibody treatment of malignant lymphoma].
Buske C, Dreyling M, Unterhalt M, Hiddemann W. Buske C, et al. Internist (Berl). 2004 Dec;45(12):1370-7. doi: 10.1007/s00108-004-1299-z. Internist (Berl). 2004. PMID: 15517123 Review. German.
[Up-to-date treatment of follicular lymphomas].
Dreyling M, Buske C, Hiddemann W. Dreyling M, et al. Among authors: buske c. Dtsch Med Wochenschr. 2005 Sep 23;130(38):2149-54. doi: 10.1055/s-2005-916357. Dtsch Med Wochenschr. 2005. PMID: 16172957 Review. German. No abstract available.
The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome.
Buske C, Hoster E, Dreyling M, Hasford J, Unterhalt M, Hiddemann W. Buske C, et al. Blood. 2006 Sep 1;108(5):1504-8. doi: 10.1182/blood-2006-01-013367. Epub 2006 May 11. Blood. 2006. PMID: 16690968 Free article. Clinical Trial.
Current management of follicular lymphomas.
Hiddemann W, Buske C, Dreyling M, Weigert O, Lenz G, Unterhalt M. Hiddemann W, et al. Among authors: buske c. Br J Haematol. 2007 Jan;136(2):191-202. doi: 10.1111/j.1365-2141.2006.06378.x. Epub 2006 Oct 31. Br J Haematol. 2007. PMID: 17073892 Free article. Review.
284 results